A protein called cFLIP makes tumor cells in breast cancer resistant to treatments

Researchers have found that cFLIP –- an inhibitor of death ligand-induced apoptosis –- is not only essential in breast tumor cells resistance to TRAIL treatments (a death ligand with a potent therapeutic potential against cancer), but this protein is also key to the survival of such cancer cells.

Read the whole article on Science Daily

More from Science Daily